Global Urological Cancer Therapeutics Drugs Market Report 2019, Competitive Landscape, Trends and Opportunities

1 Urological Cancer Therapeutics Drugs Market Overview

1.1 Product Overview and Scope of Urological Cancer Therapeutics Drugs

1.2 Urological Cancer Therapeutics Drugs Segment by Type

1.2.1 Global Urological Cancer Therapeutics Drugs Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Xofigo (radium Ra 223 dichloride)

1.2.3 The Market Profile of Jevtana (cabazitaxel)

1.2.4 The Market Profile of Inlyta (axitinib)

1.2.5 The Market Profile of Votrient (pazopanib hydrochloride)

1.2.6 The Market Profile of Sutent (sunitinib malate)

1.2.7 The Market Profile of Zytiga (abiraterone acetate)

1.2.8 The Market Profile of Xtandi (enzalutamide)

1.2.9 The Market Profile of Opdivo (nivolumab)

1.2.10 The Market Profile of Provenge (sipuleucel-T)

1.3 Global Urological Cancer Therapeutics Drugs Segment by Application

1.3.1 Urological Cancer Therapeutics Drugs Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Hospital

1.3.3 The Market Profile of Medical Research Laboratory

1.3.4 The Market Profile of Others

1.4 Global Urological Cancer Therapeutics Drugs Market by Region (2014-2026)

1.4.1 Global Urological Cancer Therapeutics Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.3 Europe Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.3.1 Germany Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.3.2 UK Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.3.3 France Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.3.4 Italy Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.3.5 Spain Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.3.6 Russia Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.3.7 Poland Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.4 China Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.5 Japan Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.6 India Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.8 Central and South America Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Urological Cancer Therapeutics Drugs Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Urological Cancer Therapeutics Drugs (2014-2026)

1.5.1 Global Urological Cancer Therapeutics Drugs Revenue Status and Outlook (2014-2026)

1.5.2 Global Urological Cancer Therapeutics Drugs Production Status and Outlook (2014-2026)

2 Global Urological Cancer Therapeutics Drugs Market Landscape by Player

2.1 Global Urological Cancer Therapeutics Drugs Production and Share by Player (2014-2019)

2.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Player (2014-2019)

2.3 Global Urological Cancer Therapeutics Drugs Average Price by Player (2014-2019)

2.4 Urological Cancer Therapeutics Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Urological Cancer Therapeutics Drugs Market Competitive Situation and Trends

2.5.1 Urological Cancer Therapeutics Drugs Market Concentration Rate

2.5.2 Urological Cancer Therapeutics Drugs Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 Pfizer

3.1.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.1.3 Pfizer Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.1.4 Pfizer Business Overview

3.2 AstraZeneca

3.2.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.2.3 AstraZeneca Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.2.4 AstraZeneca Business Overview

3.3 Roche Healthcare

3.3.1 Roche Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.3.3 Roche Healthcare Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.3.4 Roche Healthcare Business Overview

3.4 Novartis

3.4.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.4.3 Novartis Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.4.4 Novartis Business Overview

3.5 Dendreon Corporation

3.5.1 Dendreon Corporation Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.5.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.5.4 Dendreon Corporation Business Overview

3.6 Indevus Pharmaceuticals Inc

3.6.1 Indevus Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.6.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.6.4 Indevus Pharmaceuticals Inc Business Overview

3.7 Celgene Corporation

3.7.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.7.3 Celgene Corporation Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.7.4 Celgene Corporation Business Overview

3.8 Ipsen

3.8.1 Ipsen Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.8.3 Ipsen Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.8.4 Ipsen Business Overview

3.9 Sanofi S.A.

3.9.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.9.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.9.4 Sanofi S.A. Business Overview

3.10 Ferring Pharmaceuticals

3.10.1 Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.10.4 Ferring Pharmaceuticals Business Overview

3.11 GlaxoSmithKline plc

3.11.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.11.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.11.4 GlaxoSmithKline plc Business Overview

3.12 Johnson & Johnson

3.12.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.12.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.12.4 Johnson & Johnson Business Overview

3.13 Abbott Laboratories

3.13.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.13.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.13.4 Abbott Laboratories Business Overview

3.14 Astellas

3.14.1 Astellas Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.14.3 Astellas Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.14.4 Astellas Business Overview

3.15 Bristol-Myers Squibb

3.15.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Urological Cancer Therapeutics Drugs Product Profiles, Application and Specification

3.15.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Market Performance (2014-2019)

3.15.4 Bristol-Myers Squibb Business Overview

4 Global Urological Cancer Therapeutics Drugs Production, Revenue (Value), Price Trend by Type

4.1 Global Urological Cancer Therapeutics Drugs Production and Market Share by Type (2014-2019)

4.2 Global Urological Cancer Therapeutics Drugs Revenue and Market Share by Type (2014-2019)

4.3 Global Urological Cancer Therapeutics Drugs Price by Type (2014-2019)

4.4 Global Urological Cancer Therapeutics Drugs Production Growth Rate by Type (2014-2019)

4.4.1 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Xofigo (radium Ra 223 dichloride) (2014-2019)

4.4.2 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Jevtana (cabazitaxel) (2014-2019)

4.4.3 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Inlyta (axitinib) (2014-2019)

4.4.4 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Votrient (pazopanib hydrochloride) (2014-2019)

4.4.5 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Sutent (sunitinib malate) (2014-2019)

4.4.6 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Zytiga (abiraterone acetate) (2014-2019)

4.4.7 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Xtandi (enzalutamide) (2014-2019)

4.4.8 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Opdivo (nivolumab) (2014-2019)

4.4.9 Global Urological Cancer Therapeutics Drugs Production Growth Rate of Provenge (sipuleucel-T) (2014-2019)

5 Global Urological Cancer Therapeutics Drugs Market Analysis by Application

5.1 Global Urological Cancer Therapeutics Drugs Consumption and Market Share by Application (2014-2019)

5.2 Global Urological Cancer Therapeutics Drugs Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Urological Cancer Therapeutics Drugs Consumption Growth Rate of Hospital (2014-2019)

5.2.2 Global Urological Cancer Therapeutics Drugs Consumption Growth Rate of Medical Research Laboratory (2014-2019)

5.2.3 Global Urological Cancer Therapeutics Drugs Consumption Growth Rate of Others (2014-2019)

6 Global Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Urological Cancer Therapeutics Drugs Consumption by Region (2014-2019)

6.2 United States Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

6.3 Europe Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

6.4 China Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

6.5 Japan Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

6.6 India Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

7 Global Urological Cancer Therapeutics Drugs Production, Revenue (Value) by Region (2014-2019)

7.1 Global Urological Cancer Therapeutics Drugs Production and Market Share by Region (2014-2019)

7.2 Global Urological Cancer Therapeutics Drugs Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

8 Urological Cancer Therapeutics Drugs Manufacturing Analysis

8.1 Urological Cancer Therapeutics Drugs Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Urological Cancer Therapeutics Drugs Industrial Chain Analysis

9.2 Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Urological Cancer Therapeutics Drugs

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Urological Cancer Therapeutics Drugs Market Forecast (2019-2026)

11.1 Global Urological Cancer Therapeutics Drugs Production, Revenue Forecast (2019-2026)

11.1.1 Global Urological Cancer Therapeutics Drugs Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Urological Cancer Therapeutics Drugs Price and Trend Forecast (2019-2026)

11.2 Global Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Urological Cancer Therapeutics Drugs Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Urological Cancer Therapeutics Drugs Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Urological Cancer Therapeutics Drugs Product Picture

Table Global Urological Cancer Therapeutics Drugs Production and CAGR (%) Comparison by Type

Table Profile of Xofigo (radium Ra 223 dichloride)

Table Profile of Jevtana (cabazitaxel)

Table Profile of Inlyta (axitinib)

Table Profile of Votrient (pazopanib hydrochloride)

Table Profile of Sutent (sunitinib malate)

Table Profile of Zytiga (abiraterone acetate)

Table Profile of Xtandi (enzalutamide)

Table Profile of Opdivo (nivolumab)

Table Profile of Provenge (sipuleucel-T)

Table Urological Cancer Therapeutics Drugs Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Hospital

Table Profile of Medical Research Laboratory

Table Profile of Others

Figure Global Urological Cancer Therapeutics Drugs Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Europe Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Germany Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure UK Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure France Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Italy Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Spain Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Russia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Poland Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure China Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Japan Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure India Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Malaysia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Singapore Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Philippines Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Indonesia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Thailand Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Vietnam Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Central and South America Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Brazil Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Mexico Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Colombia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Turkey Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Egypt Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure South Africa Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Nigeria Urological Cancer Therapeutics Drugs Revenue and Growth Rate (2014-2026)

Figure Global Urological Cancer Therapeutics Drugs Production Status and Outlook (2014-2026)

Table Global Urological Cancer Therapeutics Drugs Production by Player (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Production Share by Player (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Share by Player in 2018

Table Urological Cancer Therapeutics Drugs Revenue by Player (2014-2019)

Table Urological Cancer Therapeutics Drugs Revenue Market Share by Player (2014-2019)

Table Urological Cancer Therapeutics Drugs Price by Player (2014-2019)

Table Urological Cancer Therapeutics Drugs Manufacturing Base Distribution and Sales Area by Player

Table Urological Cancer Therapeutics Drugs Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table Pfizer Profile

Table Pfizer Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table AstraZeneca Profile

Table AstraZeneca Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Roche Healthcare Profile

Table Roche Healthcare Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Novartis Profile

Table Novartis Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Dendreon Corporation Profile

Table Dendreon Corporation Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Indevus Pharmaceuticals Inc Profile

Table Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Celgene Corporation Profile

Table Celgene Corporation Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Ipsen Profile

Table Ipsen Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Sanofi S.A. Profile

Table Sanofi S.A. Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Ferring Pharmaceuticals Profile

Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table GlaxoSmithKline plc Profile

Table GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Johnson & Johnson Profile

Table Johnson & Johnson Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Abbott Laboratories Profile

Table Abbott Laboratories Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Astellas Profile

Table Astellas Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Bristol-Myers Squibb Profile

Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Production by Type (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Production Market Share by Type (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Market Share by Type in 2018

Table Global Urological Cancer Therapeutics Drugs Revenue by Type (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type in 2018

Table Urological Cancer Therapeutics Drugs Price by Type (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Xofigo (radium Ra 223 dichloride) (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Jevtana (cabazitaxel) (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Inlyta (axitinib) (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Votrient (pazopanib hydrochloride) (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Sutent (sunitinib malate) (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Zytiga (abiraterone acetate) (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Xtandi (enzalutamide) (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Opdivo (nivolumab) (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Growth Rate of Provenge (sipuleucel-T) (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Consumption by Application (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Consumption Market Share by Application (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Consumption of Hospital (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Consumption of Medical Research Laboratory (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Consumption of Others (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Consumption by Region (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Consumption Market Share by Region (2014-2019)

Table United States Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

Table Europe Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

Table China Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

Table Japan Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

Table India Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

Table Central and South America Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Urological Cancer Therapeutics Drugs Production, Consumption, Export, Import (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Production by Region (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Production Market Share by Region (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Market Share by Region (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Production Market Share by Region in 2018

Table Global Urological Cancer Therapeutics Drugs Revenue by Region (2014-2019)

Table Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region (2014-2019)

Figure Global Urological Cancer Therapeutics Drugs Revenue Market Share by Region in 2018

Table Global Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table China Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table India Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Urological Cancer Therapeutics Drugs Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Urological Cancer Therapeutics Drugs

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Urological Cancer Therapeutics Drugs

Figure Urological Cancer Therapeutics Drugs Industrial Chain Analysis

Table Raw Materials Sources of Urological Cancer Therapeutics Drugs Major Players in 2018

Table Downstream Buyers

Figure Global Urological Cancer Therapeutics Drugs Production and Growth Rate Forecast (2019-2026)

Figure Global Urological Cancer Therapeutics Drugs Revenue and Growth Rate Forecast (2019-2026)

Figure Global Urological Cancer Therapeutics Drugs Price and Trend Forecast (2019-2026)

Table United States Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table China Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table India Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Urological Cancer Therapeutics Drugs Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Urological Cancer Therapeutics Drugs Market Production Forecast, by Type

Table Global Urological Cancer Therapeutics Drugs Production Volume Market Share Forecast, by Type

Table Global Urological Cancer Therapeutics Drugs Market Revenue Forecast, by Type

Table Global Urological Cancer Therapeutics Drugs Reven